These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34770925)
1. Identification of Potent Natural Resource Small Molecule Inhibitor to Control Rahaman A; Almalki AA; Rafeeq MM; Akhtar O; Anjum F; Mashraqi MM; Sain ZM; Alzamami A; Ahmad V; Zeng XA; Jamal QMS Molecules; 2021 Oct; 26(21):. PubMed ID: 34770925 [No Abstract] [Full Text] [Related]
2. MurB as a target in an alternative approach to tackle the Vibrio cholerae resistance using molecular docking and simulation study. Ragunathan A; Malathi K; Anbarasu A J Cell Biochem; 2018 Feb; 119(2):1726-1732. PubMed ID: 28786497 [TBL] [Abstract][Full Text] [Related]
4. Pharmacoinformatics and molecular dynamics simulation approach to identify anti-diarrheal potentials of Al-Mamun A; Ahammad I; Ahmed SS; Akter F; Hossain SI; Chowdhury ZM; Bhattacharjee A; Das KC; Keya CA; Salimullah M J Biomol Struct Dyn; 2023; 41(24):14730-14743. PubMed ID: 36927394 [No Abstract] [Full Text] [Related]
5. Crystal structure of the outer membrane protein OmpU from Vibrio cholerae at 2.2 Å resolution. Li H; Zhang W; Dong C Acta Crystallogr D Struct Biol; 2018 Jan; 74(Pt 1):21-29. PubMed ID: 29372896 [TBL] [Abstract][Full Text] [Related]
6. Molecular docking and molecular dynamics studies of natural products unravel potential inhibitors against OmpA of Singothu S; Devsani N; Jahidha Begum P; Maddi D; Bhandari V J Biomol Struct Dyn; 2024 Oct; 42(17):9064-9075. PubMed ID: 37646649 [TBL] [Abstract][Full Text] [Related]
7. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation. Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665 [TBL] [Abstract][Full Text] [Related]
8. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT. Mondal SI; Khadka B; Akter A; Roy PK; Sultana R Interdiscip Sci; 2014 Jun; 6(2):108-17. PubMed ID: 25172449 [TBL] [Abstract][Full Text] [Related]
9. A Tail Fiber Protein and a Receptor-Binding Protein Mediate ICP2 Bacteriophage Interactions with Vibrio cholerae OmpU. Lim ANW; Yen M; Seed KD; Lazinski DW; Camilli A J Bacteriol; 2021 Jun; 203(13):e0014121. PubMed ID: 33875544 [TBL] [Abstract][Full Text] [Related]
10. The Vibrio cholerae ToxR-regulated porin OmpU confers resistance to antimicrobial peptides. Mathur J; Waldor MK Infect Immun; 2004 Jun; 72(6):3577-83. PubMed ID: 15155667 [TBL] [Abstract][Full Text] [Related]
11. The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species. Provenzano D; Schuhmacher DA; Barker JL; Klose KE Infect Immun; 2000 Mar; 68(3):1491-7. PubMed ID: 10678965 [TBL] [Abstract][Full Text] [Related]
13. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181 [TBL] [Abstract][Full Text] [Related]
14. A Novel Rasouli Jazi HR; Zeinoddini M; Arab SS Curr Comput Aided Drug Des; 2023; 19(6):416-424. PubMed ID: 36703590 [TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of the gene encoding the OmpU outer membrane protein of Vibrio cholerae. Sperandio V; Bailey C; Girón JA; DiRita VJ; Silveira WD; Vettore AL; Kaper JB Infect Immun; 1996 Dec; 64(12):5406-9. PubMed ID: 8945596 [TBL] [Abstract][Full Text] [Related]
16. Employing virtual screening and molecular dynamics simulations for identifying hits against the active cholera toxin. Gangopadhyay A; Chakraborty HJ; Datta A Toxicon; 2019 Dec; 170():1-9. PubMed ID: 31494206 [TBL] [Abstract][Full Text] [Related]
17. Porins of Vibrio cholerae: purification and characterization of OmpU. Chakrabarti SR; Chaudhuri K; Sen K; Das J J Bacteriol; 1996 Jan; 178(2):524-30. PubMed ID: 8550475 [TBL] [Abstract][Full Text] [Related]
18. A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT. Woodbrey AK; Onyango EO; Pellegrini M; Kovacikova G; Taylor RK; Gribble GW; Kull FJ Sci Rep; 2017 Mar; 7():45011. PubMed ID: 28332578 [TBL] [Abstract][Full Text] [Related]
19. Naturally Occurring IgG Antibodies Provide Innate Protection against Vibrio cholerae Bacteremia by Recognition of the Outer Membrane Protein U. Aung KM; Sjöström AE; von Pawel-Rammingen U; Riesbeck K; Uhlin BE; Wai SN J Innate Immun; 2016; 8(3):269-83. PubMed ID: 26934383 [TBL] [Abstract][Full Text] [Related]
20. Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Demir-Yazıcı K; Güzel-Akdemir Ö; Angeli A; Supuran CT; Akdemir A Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]